B Cell Prolymphocytic Leukemia - 14 Studies Found

Not yet recruiting : Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
:
  • Anemia
  • B-Cell Prolymphocytic Leukemia
  • Drug: Entospletinib Given PO
Recruiting : Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
:
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia

  • : 2016-09-14
    : Biological: XmAb13676 Biological
Withdrawn : Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML
:
  • Lymphoproliferative Malignancies
  • Acute Myeloid Leukemia

: 2014-08-28
: Drug: ZEN003365
Active, not recruiting : Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
: Leukemia
: 2010-03-25
: Drug: Nelarabine Starting dose 200 mg/m2 for 5 day continuous infusion administered via a central cathet
<<< Previous